OR WAIT null SECS
August 03, 2022
Ipsen and Marengo Therapeutics will collaborate to advance two precision immuno-oncology candidates.
August 02, 2022
CRYOPDP is expanding its footprint to Spain with its acquisition of Polar Expres.
Bio-Rad has expanded its range of recombinant monoclonal anti-idiotypic antibodies.
The new facility in Albany, Ore., will support biopharmaceutical development and lyophilization services.
Novasep-PharmaZell will increase API production capacity at its Mourenx site with €7.3M investment.
Pharma’s leveraging real-world evidence to drive product approval, reimbursement, and market access.
FDA’s hybrid inspection model will remain a regular means for supplementing onsite inspections and will be further integrated into the agency’s oversight operations.
GSK has completed its demerger of Haleon and has signed an agreement to help support future pandemic preparedness in Europe.
August 01, 2022
DuPont’s new manufacturing site will expand its biopharmaceutical tubing manufacturing capabilities.
The United States has agreed to purchase 66 million doses of Moderna’s bivalent COVID-19 booster candidate for $1.74 billion.